Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,361 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Recruiting

Collection of Tissue Samples for Cancer Research

NCT00900198

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +18 more
Locations: UC Davis Sacramento, California, United States

University of Colorado, Denver Aurora, Colorado, United States

Emory University Atlanta, Georgia, United States

Indiana University - Purdue Indianapolis, Indiana, United States

View all 17 locations

View Trial Details

Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT04195633

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +59 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

NCT04953910

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: MD Anderson Houston, Texas, United States

Erebuni Medical Center Yerevan, Armenia

Hematology Center After Prof. R. Yeolyan (Adult Blood Disorders) Yerevan, Armenia

Hematology Center After Prof. R. Yeolyan (Clinic of Adults Oncology) Yerevan, Armenia

View all 22 locations

View Trial Details

Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

NCT04953897

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: MD Anderson Houston, Texas, United States

Erebuni Medical Center Yerevan, Armenia

Hematology Center After Prof. R. Yeolyan (Adult Blood Disorders) Yerevan, Armenia

Hematology Center After Prof. R. Yeolyan (Clinic of Adults Oncology) Yerevan, Armenia

View all 21 locations

View Trial Details

Recruiting

A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

NCT04239157

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

NCT02115295

Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Crisis, +36 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

NCT03326921

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

NCT04187703

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

NCT06287944

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

NCT06928662

Conditions: Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Bone Marrow Diseases, +32 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions